Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26

Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer

(2014) Benoît Romain et al.   Molecular Cancer

Prognostic Significance of CD26 in Patients with Colorectal Cancer

(2014) Colin Siu-Chi Lam et al.   PLoS One

Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer

(2013) C-Y Lu et al.   BRITISH JOURNAL OF CANCER

miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression

(2013) Fang-Ting Duan et al.   Molecular Cancer

CD133+CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patients

(2012) Shan-shan Zhang et al.   BMC Medicine

Co-expression of CD133+/CD44+in human colon cancer and liver metastasis

(2012) Antonia Bellizzi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Cells of origin in cancer

(2011) Jane E. Visvader   NATURE

A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer

(2010) Roberta Pang et al.   Cell Stem Cell

Colorectal cancer

(2010) David Cunningham et al.   LANCET

Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition

(2009) N. A. Dallas et al.   CANCER RESEARCH

Control of Chemokine-Guided Cell Migration by Ligand Sequestration

(2008) Bijan Boldajipour et al.   CELL

CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12

(2008) Yan-Xi Sun et al.   CLINICAL & EXPERIMENTAL METASTASIS

Chemotherapy for Colorectal Cancer Liver Metastases

(2008) S. R. Alberts et al.   ONCOLOGIST

Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy

(2008) Scott J. Dylla et al.   PLoS One